a rare case of a symptomatic tumor found in the groin area: an atypical location unexposed to the known causes

Clicks: 260
ID: 147481
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #35 of 83 articles by views in multi-span large bridges - proceedings of the international conference on multi-span large bridges, 2015

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms. The syndrome consists of early-onset and/or multiple BCC. Herein we report a rare NBCCS case in which the first BCC onset occurred in the groin area. To the best of our knowledge, there have been no reports of first-onset BCC in the groin area in an NBCCS patient of any race.
Reference Key
toyonaga2015casea Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Ellen Toyonaga;Hiroo Hata;Chihiro Nakayama;Erina Homma;Toshiyuki Miyashita;Hiroshi Shimizu
Journal multi-span large bridges - proceedings of the international conference on multi-span large bridges, 2015
Year 2015
DOI
10.1159/000442148
URL
http://www.karger.com/Article/FullText/442148
Keywords
basal cell carcinoma gorlin syndrome Oncology including cancer and carcinogens tumors groin areaneoplasms

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.